Search

everythinglearnresearchcommunity

for

Search:↓

Sertraline, an antidepressant, may cause hair loss in rare cases.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

A toddler with a rare adrenal gland tumor causing male-like physical changes was successfully treated with surgery.

Age, health conditions, race, and gender affect COVID-19 risk.

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

Losing weight, fixing varicoceles, and using advanced sperm selection methods improve male infertility treatment outcomes.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

Effective vaccines and treatments are crucial for long-term COVID-19 control.

Cryotherapy helps reduce chemotherapy side effects but needs more research for best use.

Methotrexate is not proven to maintain remission in ulcerative colitis.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

Photobiomodulation is safe for skin rejuvenation, even for those with a cancer history.

A new mouse model effectively mimics vitiligo for research and drug testing.

Reducing accidents and treating vascular diseases can lower the need for life-impacting amputations.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

PRP treatment may help with alopecia areata, especially in newer cases.

COVID-19 can cause hair and nail disorders after infection.

A certain mutation in the fetal alpha 5-reductase gene is linked to a higher risk of late miscarriage.

Greasy hair spreads sebum twice as much as nongreasy hair over time.

Cronkhite-Canada syndrome is a rare condition causing gut polyps, hair loss, skin changes, and nail issues, often with a poor outlook.

Removing Mediator 1 from certain mouse cells causes teeth to grow hair instead of enamel.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

Umbilical cord blood is a valuable source of stem cells for medical treatments, but its use is less common than other transplants, and there are ethical issues to consider.

Alopecia areata has a high chance of persisting and relapsing, with a significant risk of total hair loss, especially if it starts in childhood.